Do you want to read an article? Please log in or register.
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
Further Publications
![](https://cdn.healthbook.network/wp-content/uploads/2018/03/like_hb.png)